Bright Peak Therapeutics raised $107M series B w/ Versant Ventures, RA Capital Management, Qatar Investment Authority, Invus, Fidelity, BlackRock Biotech Health services Pharma Investments 04 June 2021 Share:
Round value (USD): 107m Round investors: BlackRock Fidelity Investments Invus RA Capital Management Qatar Investment Authority Alexandria Venture Investments Versant Ventures Company: Bright Peak Therapeutics Industry: Biotech Health services Pharma
MindMaze raised $125M from AlbaCore Capital Biotech Competitive Intelligence Health services Software Services Investments 19 October 2021
Numab Therapeutics in a CHF 100 Million series C round led by Novo Holdings Biotech Health services Investments 20 May 2021